Big Tree Cloud Holdings Valuation

Q: What is the Fair Price of DSY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

DSY ($2.29) is trading above our estimate of [[fair value]] ($1.31)

Is DSY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DSY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DSY ($2.29) is trading above our estimate of fair value ($1.31)

Significantly Below Fair Value: DSY is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DSY?

Key metric: As DSY is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DSY. This is calculated by dividing DSY's market cap by their current revenue.
What is DSY's PS Ratio?
PS Ratio	16.4x
Sales	US$7.98m
Market Cap	US$131.29m

DSY key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	16.5x
Enterprise Value/EBITDA	70x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does DSY's PS Ratio compare to its peers?

The above table shows the PS ratio for DSY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1x
FTLF FitLife Brands	2.4x	9.2%	US$147.2m
LFVN LifeVantage	0.9x	5.0%	US$164.8m
MED Medifast	0.3x	-13.4%	US$194.9m
SKIN Beauty Health	0.5x	5.7%	US$172.5m
DSY Big Tree Cloud Holdings	16.4x	n/a	US$131.3m

Price-To-Sales vs Peers: DSY is expensive based on its Price-To-Sales Ratio (16.4x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does DSY's PS Ratio compare vs other companies in the US Personal Products Industry?

26 Companies	Price / Sales	Estimated Growth	Market Cap
HLF Herbalife	0.2x	1.8%	US$856.73m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$362.89m
MED Medifast	0.3x	-13.4%	US$194.93m
SKIN Beauty Health	0.5x	5.7%	US$172.53m

26 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: DSY is expensive based on its Price-To-Sales Ratio (16.4x) compared to the US Personal Products industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is DSY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DSY PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	16.4x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate DSY's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Kimberly-Clark de México S. A. B. de C. V

Mex$86.6b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

-5.8%

n/a

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.76

1.9%

6.4%

Unicharm

JP¥2.2t

Engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally.

UNCH.F

JP¥23.64

-10.8%

-28.9%